Introduction
Hepatitis B virus (HBV) infection in pregnant women is a serious threat to infants. The risk of developing chronic HBV infection in infants born to HBeAg-positive mother is 70-90% and the risk is 10-31% for infants born to HBeAg-negative mother. [1, 2] Mother-to-child transmission of HBV can be prevented by providing infants with hepatitis B immunoglobulin (HBIG) and HBV vaccine within 12 hours of birth. [3] India introduced the HBV vaccine in 10 states including Andhra Pradesh, Himachal Pradesh, Jammu and Kashmir, Karnataka, Kerala, Madhya Pradesh, Maharashtra, Punjab, Tamil Nadu, and West Bengal as part of its Universal Immunization Program (UIP) in 2007-08. [4] Here, we demonstrate mother-to-child transmission of HBV in three families from Jharkhand and Bihar states where HBV vaccination is not included in the UIP.
Case Reports

Case 1
On 11 th January 2013, four children between 4-10 years of age from a family in Jharkhand state were referred to the department of Clinical Virology for quantitative HBV DNA estimation. All children tested positive for hepatitis B surface antigen (HBsAg). They were screened for HBV as the mother was detected positive for HBsAg on routine preoperative screening. On testing of additional HBV markers, all were positive for HBeAg and HBV DNA levels ranged between 8.7 and 9.6 log 10 IU/mL [ Figure 1 ]. Liver function tests and ultrasound of the abdomen were normal. Samples were collected from the parents for additional investigation. The mother was also detected to be HBeAg February S141 and subtype ayw2 [ Figure 2 ]. The remaining one HBV DNA positive sample could not be sequenced as the HBV DNA levels was low (1.76 log 10 IU/mL) and therefore failed sequence analysis.
Discussion
In regions of high HBV endemicity, World Health Organization (WHO) recommends HBV vaccination at birth to prevent mother-to-child transmission, independent of the HBV maternal status. In intermediate and low HBV-endemic region, selective immunization of infants born to HBsAg-positive mothers is recommended. HBV vaccine has reduced the rate of hepatitis B prevalence and its associated sequelae. Therefore, WHO Expanded Program of Immunization (EPI) recommend HBV vaccination in the national immunization program for all countries (Reviewed by Denis and Ranger-Rogez, 2004 [5] ).
In our study, it is very evident that the children were infected with HBV through vertical transmission, particularly evident in cases 2 and 3 where HBV seems to have been transmitted across two generations. This clearly illustrates the need for active screening of HBV in all pregnant women and immunization of infants born to HBV infected mothers. Due to transmission so early in life, chronic infection was established with high HBV DNA levels, also increasing risk in long term sequelae. HBV DNA levels in the HBeAg-positive mother (case 1) were relatively low (6 log 10 IU/mL) as she was continuing antiviral therapy. Interestingly, the male members (adults) in the described cases have been exposed to HBV and show evidence of natural clearance.
In case 3, HBV DNA levels tested in both mothers (generation 1 and generation 2) were lower and were HBeAg-negative. Child 2 in generation 2 received only two doses of HBV vaccine, and hence showed markers of HBV infection. This further reiterates the need for administration of the recommended 3 dose of vaccine to ensure protection against HBV infection.
Among the children born to the HBeAg-positive mother in cases 1 and 2, 9 (90%) had high HBV DNA levels of >7.48 log 10 IU/mL. The remaining one child described in case 2 had low HBV DNA levels (2.42 log 10 IU/mL) with anti-HBe seroconversion. The study results thus correspond to the earlier reported proportion of HBV-infected infants at increased risk for developing chronic HBV infection. [1, 2] As observed in this study, India has a predominant HBV genotype D circulation. A previous study from the Indian subcontinent showed the association of genotype D with severe liver disease and HCC as compared to genotype A in young adults. [6] Since mother-to-child transmission increases the risk of developing chronic HBV infection, active screening of HBsAg in all pregnant women is recommended. Additionally, implementation of HBV vaccine across all states in countries like India with intermediate HBV endemicity would reduce the burden of disease as demonstrated in Taiwan and Italy. [7, 8] On phylogenetic analysis all sequences from the respective family members clustered closely together. The nucleotide similarity between the sequences ranged between 99.6 and 100%, indicating the sequences are very close to identical. This cannot exclusively prove motherto-child transmission as there is a likely chance of horizontal transmission in early childhood. However, in a meta-analysis survey, it was shown that unlike vertical or sexual transmission of HBV, horizontal route is a less effi cient mode of transmission. [9] We show evidence of three or more children in each generation to be infected with HBV and with large age differences in some cases. Therefore, the probability that every child in the family acquired HBV through saliva or open wound is less likely. These points strongly suggest that mother-to-child transmission would be the major mode of HBV transmission in all three families. The demonstration of the same strain in siblings across generations in these families, reiterates the importance of neonatal HBV vaccination as it prevents against both forms of familial transmission.
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